Risk of myocardial infarction in patients with psoriasis.
By J. Gelfand, A. Neimann, D. Shin, Xingmei Wang, D. Margolis, Andrea B. Troxel. Journal of the American Medical Association (JAMA), 2006
1,984 citations recorded by the source corpus.
Subfields: Immunology, Rheumatology
View Paper: https://www.semanticscholar.org/paper/12bc61b9d779450fc15cfb7d75ef6676c345cab1
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Rheumatology
- Andrea B. Troxel
- J. Gelfand
- I. Graham
- George Davey Smith
- Stephen Burgess
- S. Thompson
- J. Bowden
- Gibran Hemani
Citations in the corpus
- Treatment recommendations for psoriatic arthritis (2008, background): “Moreover, comorbidities associated with psoriasis such as the metabolic syndrome can contribute to damage in multiple end-organs and often leads to markedly impaired QoL as well as early mortality.”
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. (2010, background): “Our data are consistent with recent studies that demonstrate that psoriasis is an independent risk factor for coronary artery disease, 12–15 stroke, 15,23 and MI. 12,15 Our study builds upon previous findings that severe psoriasis patients have an increased relative risk CV mortality that is highest ”
- The risk of depression, anxiety and suicidality in patients with psoriasis: A population-based cohort study (2010, methodology): “excess cardiovascular risk and mortality in patients with more severe disease.(2-4) Pso-”
- Psoriasis and Comorbid Diseases Part I. Epidemiology (2017, positive): “However, in 2006, a large, population-based cohort study in the United Kingdom found that psoriasis was associated with an increased risk of MI, independent of traditional risk factors, such as body mass index (BMI), smoking, hypertension, diabetes, and dyslipidemia.(11) Moreover, a dose-response ef”
- European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (Version 2012) (2012, positive): “Patients in whom the psoriasis was classified as severe had a higher risk of myocardial infarction than patients with mild psoriasis, consistent with the hypothesis that greater immune activity in psoriasis is related to a higher risk of myocardial infarction and cardiovascular death.(185,186)”
- Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis (2009, positive): “Circulating Th17 cells could also have a role in systemic inflammation observed in psoriasis patients, including psoriatic arthritis and atherosclerosis (Gelfand et al., 2006).”